INTEGRA LIFESCIENCES HOLDING (IART) Stock Price & Overview

NASDAQ:IART • US4579852082

Current stock price

8.94 USD
+0.04 (+0.45%)
At close:
8.94 USD
0 (0%)
After Hours:

The current stock price of IART is 8.94 USD. Today IART is up by 0.45%. In the past month the price decreased by -26.14%. In the past year, price decreased by -60.43%.

IART Key Statistics

52-Week Range8.76 - 22.96
Current IART stock price positioned within its 52-week range.
1-Month Range8.76 - 12.375
Current IART stock price positioned within its 1-month range.
Market Cap
696.784M
P/E
4.01
Fwd P/E
3.75
EPS (TTM)
2.23
Dividend Yield
N/A

IART Stock Performance

Today
+0.45%
1 Week
-2.94%
1 Month
-26.14%
3 Months
-29.64%
Longer-term
6 Months -37.01%
1 Year -60.43%
2 Years -74.89%
3 Years -84.50%
5 Years -87.12%
10 Years -47.15%

IART Stock Chart

INTEGRA LIFESCIENCES HOLDING / IART Daily stock chart

IART Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to IART. When comparing the yearly performance of all stocks, IART is a bad performer in the overall market: 93.44% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

IART Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to IART. Both the profitability and financial health of IART have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IART Earnings

On February 26, 2026 IART reported an EPS of 0.83 and a revenue of 434.93M. The company beat EPS expectations (1.67% surprise) and missed revenue expectations (-0.75% surprise).

Next Earnings DateMay 4, 2026
Last Earnings DateFeb 26, 2026
PeriodQ4 / 2025
EPS Reported$0.83
Revenue Reported434.925M
EPS Surprise 1.67%
Revenue Surprise -0.75%

IART Forecast & Estimates

17 analysts have analysed IART and the average price target is 15.81 USD. This implies a price increase of 76.85% is expected in the next year compared to the current price of 8.94.

For the next year, analysts expect an EPS growth of 7.01% and a revenue growth 2.71% for IART


Analysts
Analysts54.12
Price Target15.81 (76.85%)
EPS Next Y7.01%
Revenue Next Year2.71%

IART Groups

Sector & Classification

IART Financial Highlights

Over the last trailing twelve months IART reported a non-GAAP Earnings per Share(EPS) of 2.23. The EPS decreased by -12.89% compared to the year before.


Income Statements
Revenue(TTM)1.64B
Net Income(TTM)-516.47M
Industry RankSector Rank
PM (TTM) N/A
ROA -14.34%
ROE -49.5%
Debt/Equity 1.66
Chartmill High Growth Momentum
EPS Q2Q%-14.43%
Sales Q2Q%-1.74%
EPS 1Y (TTM)-12.89%
Revenue 1Y (TTM)1.53%

IART Ownership

Ownership
Inst Owners97.52%
Shares77.94M
Float66.88M
Ins Owners3%
Short Float %11.18%
Short Ratio9.81

About IART

Company Profile

IART logo image Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. The company is headquartered in Princeton, New Jersey and currently employs 4,427 full-time employees. The firm manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.

Company Info

IPO: 1995-08-16

INTEGRA LIFESCIENCES HOLDING

1100 Campus Road

Princeton NEW JERSEY 08540 US

CEO: Peter J. Arduini

Employees: 4396

IART Company Website

IART Investor Relations

Phone: 16092750500

INTEGRA LIFESCIENCES HOLDING / IART FAQ

Can you describe the business of INTEGRA LIFESCIENCES HOLDING?

Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. The company is headquartered in Princeton, New Jersey and currently employs 4,427 full-time employees. The firm manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.


What is the current price of IART stock?

The current stock price of IART is 8.94 USD. The price increased by 0.45% in the last trading session.


Does IART stock pay dividends?

IART does not pay a dividend.


How is the ChartMill rating for INTEGRA LIFESCIENCES HOLDING?

IART has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


On which exchange is IART stock listed?

IART stock is listed on the Nasdaq exchange.


What sector and industry does INTEGRA LIFESCIENCES HOLDING belong to?

INTEGRA LIFESCIENCES HOLDING (IART) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


How many employees does INTEGRA LIFESCIENCES HOLDING have?

INTEGRA LIFESCIENCES HOLDING (IART) currently has 4396 employees.